Top 50 Medical VC Funds & Investors in France (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Bpifrance
VC Fund
|
72 | France, United States, Switzerland | Seed, Venture - Series Unknown, Series A | Software, Health Care, Biotechnology | $752k–$34M |
|
Kurma Partners
VC Fund
|
19 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Pharmaceutical | $2.8M–$98M |
|
Karista
VC Fund
|
15 | France, United States, Finland | Seed, Series A, Series B | Software, Biotechnology, Health Care | $768k–$33M |
|
Sofinnova Partners
VC Fund
|
13 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $7M–$105M |
|
Idinvest Partners
VC Fund
|
13 | France, United States, Germany | Series A, Series B, Venture - Series Unknown | Software, Health Care, Biotechnology | $3.4M–$66M |
|
GO CAPITAL
VC Fund
|
11 | France, Canada, Israel | Seed, Venture - Series Unknown, Series A | Software, Biotechnology, Health Care | $549k–$13M |
|
Seventure Partners
VC Fund
|
11 | France, United States, Germany | Series A, Series B, Seed | Biotechnology, Software, Health Care | $1.1M–$63M |
|
Sofimac Investment Managers
VC Fund
|
8 | France, Italy, Austria | Venture - Series Unknown, Seed | Health Care, Biotechnology, Manufacturing | $268k–$8.7M |
|
Angels Santé
VC Fund
|
8 | France, India, United States | Seed, Venture - Series Unknown, Angel | Health Care, Biotechnology, Medical Device | $664k–$8.2M |
|
KREAXI
VC Fund
|
8 | France, Italy, Switzerland | Seed, Venture - Series Unknown, Series A | Software, Manufacturing, SaaS | $648k–$16M |
|
LBO France
VC Fund
|
8 | France, United Kingdom, Spain | Series A, Venture - Series Unknown, Series B | Health Care, Software, Medical | $2.9M–$200M |
|
Octalfa
VC Fund
|
8 | France | Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $658k–$4.6M |
|
Kima Ventures
VC Fund
|
8 | France, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, SaaS | $561k–$16M |
|
Elaia
VC Fund
|
8 | France, United States, Spain | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.1M–$50M |
|
M Capital Partners
VC Fund
|
7 | France, United States, Canada | Venture - Series Unknown, Seed | Health Care, Software, Food and Beverage | $1.1M–$5.6M |
|
Kerala Ventures
VC Fund
|
7 | France | Seed, Series A, Venture - Series Unknown | SaaS, Rental, Internet | $336k–$14M |
|
XAnge
VC Fund
|
7 | France, Germany, Belgium | Seed, Series A, Series B | Software, SaaS, Health Care | $1.1M–$75M |
|
Crédit Agricole
VC Fund
|
7 | France, United States, Italy | Debt Financing, Seed | Energy, Health Care, Software | $837k–$1.3B |
|
Auriga Partners
VC Fund
|
7 | France, United States, Switzerland | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $2.4M–$38M |
|
BNP Paribas Développement
VC Fund
|
7 | France, Germany, The Netherlands | Venture - Series Unknown, Series A, Seed | Software, Health Care, Information Technology | $2M–$27M |
|
Sham Innovation Santé
VC Fund
|
6 | France | Series B, Series A, Venture - Series Unknown | Biotechnology, Medical Device, Medical | $1.8M–$80M |
|
Finovam Gestion
VC Fund
|
6 | France, United States | Seed, Series A | Software, Information Technology, Medical | $513k–$18M |
|
MACSF
VC Fund
|
6 | France, Spain, Ecuador | Series A, Seed, Venture - Series Unknown | Health Care, Artificial Intelligence, Medical Device | $1.1M–$80M |
|
Nord France Amorcage
VC Fund
|
6 | France, United States | Seed, Venture - Series Unknown, Series A | Software, Health Care, Information Technology | $421k–$25M |
|
IRDI SORIDEC Gestion
VC Fund
|
6 | France, Brazil, Singapore | Seed, Series A, Venture - Series Unknown | Software, Biotechnology, Medical | $1.3M–$13M |
|
Extens
VC Fund
|
5 | France | Venture - Series Unknown, Private Equity | Medical, Health Care, Apps | $1.4M–$8.5M |
|
Banque des Territoires
VC Fund
|
5 | France, United States | Seed, Series A | Software, Information Technology, Health Care | $1.4M–$30M |
|
Isai
VC Fund
|
5 | France, United States, United Kingdom | Series A, Seed, Series B | Software, Information Technology, Artificial Intelligence | $999k–$50M |
|
ODYSSEE VENTURE
VC Fund
|
5 | France, United States | Venture - Series Unknown, Series A, Seed | Software, Information Technology, SaaS | $878k–$16M |
|
IRDI
VC Fund
|
5 | France | Series A, Venture - Series Unknown, Seed | Health Care, Software, Biotechnology | $757k–$23M |
|
Crédit Mutuel Innovation
VC Fund
|
5 | France, United States, Belgium | Series A, Venture - Series Unknown | Software, Health Care, Biotechnology | $2.4M–$26M |
|
Entrepreneurs First
VC Fund
|
5 | United Kingdom, Singapore, United States | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Machine Learning | $54k–$41M |
|
Newfund
VC Fund
|
5 | France, United States, Canada | Seed, Series A, Venture - Series Unknown | Software, Information Technology, Artificial Intelligence | $850k–$15M |
|
IXO Private Equity
VC Fund
|
5 | France, United States, Canada | Private Equity, Venture - Series Unknown, Series A | Health Care, Manufacturing, Biotechnology | $1.8M–$22M |
|
Innovacom
VC Fund
|
4 | France, United States, Canada | Series A, Series B, Series C | Software, Mobile, Telecommunications | $2.7M–$58M |
|
Bpifrance Digital Venture
VC Fund
|
4 | France, India | Series A, Seed, Pre-Seed | Artificial Intelligence, Software, Health Care | $439k–$21M |
|
Partech
VC Fund
|
4 | France, United States, Germany | Seed, Series A, Series B | Software, Artificial Intelligence, E-Commerce | $1M–$56M |
|
Paris-Saclay Seed Fund
VC Fund
|
4 | France | Series A, Seed, Series B | Medical, Health Care, Biotechnology | $2.3M–$22M |
|
Pays de la Loire Participations
VC Fund
|
4 | France | Seed, Venture - Series Unknown, Private Equity | Manufacturing, Software, Information Technology | $559k–$5.8M |
|
iBionext
VC Fund
|
4 | France | Venture - Series Unknown, Series A, Series B | Medical Device, Artificial Intelligence, Drones | $2.7M–$39M |
|
Région Sud Investissement
VC Fund
|
4 | France, Spain | Seed, Series A, Venture - Series Unknown | Software, Information Technology, Manufacturing | $1.1M–$24M |
|
Ventech
VC Fund
|
4 | France, Germany, United States | Series A, Seed, Series B | Software, Artificial Intelligence, SaaS | $1.3M–$67M |
|
Cemag Invest
VC Fund
|
4 | France | Series B, Series A, Private Equity | Medical, Health Care, Artificial Intelligence | $7.5M–$34M |
|
Sham
VC Fund
|
4 | France, United States | Series B, Series A, Venture - Series Unknown | Medical Device, Biotechnology, Health Care | $1.8M–$80M |
|
Cap Innov'Est
VC Fund
|
4 | France, United States | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Medical | $706k–$8.3M |
|
CentraleSupélec Venture
VC Fund
|
4 | France | Seed, Pre-Seed | Medical, Biotechnology, Artificial Intelligence | $412k–$5.8M |
|
Galia Gestion
VC Fund
|
4 | France, United States | Venture - Series Unknown, Series A | Software, Manufacturing, Biotechnology | $849k–$11M |
|
European Investment Bank
VC Fund
|
4 | France, Germany, Spain | Debt Financing, Post-IPO Debt, Venture - Series Unknown | Biotechnology, Energy, Health Care | $8.7M–$587M |
|
WiSEED
VC Fund
|
4 | France, Norway | Seed, Venture - Series Unknown, Series A | Software, Biotechnology, Manufacturing | $392k–$7.8M |
|
Crédit Mutuel Equity
VC Fund
|
4 | France, Canada, Germany | Private Equity, Venture - Series Unknown, Series A | Manufacturing, Health Care, Food and Beverage | $2.6M–$89M |
| Access all 716 VC funds in France Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: France, United States, Switzerland
Investor stats
- Total investments: 1710
- Round size: Seed $752k–$6.1M; Series A $2.6M–$34M; Venture - Series Unknown $1.1M–$31M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely actively investing — fresh fund, raised $27M in 2025
Portfolio highlights
- Cube — Cube is a French accelerator for tech startups, particularly in Web3, blockchain, and innovation, rebranded from Cube3. It provides a 9-month program combining strategic mentoring, customized funding, media production, and investor networking to scale promising ventures.
- Ostrea — OSTREA is a pioneering company in the creation of high-performance materials based on bio-minerals: seashells.
- NeoXperiences — NeoXperiences develops technological solutions that bring audiences together around fun and interactive experiences.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 145
- Round size: Seed $2.8M–$14M; Series A $3.9M–$98M; Series B $12M–$72M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $236M in 2024
Portfolio highlights
- Tacalyx — Tacalyx develops therapeutics targeting cancer-specific carbohydrate antigens on the surface of metastatic malignant tumors where no satisfactory treatments exist.The name Tacalyx is derived from TACA (Tumor Associated Carbohydrate Antigen) and ‘lyx’ from the term Glycocalyx, the glycan-containing layer covering cells. Cancer cells differ fromnormal cells by displaying aberrant carbohydrate structures on their surfaces promoting metastasis, angiogenesis or suppression of the immune system. TACAs result from the aberrant glycosylation that is seen with transformation to a tumor cell and represent attractive targets for cancer treatment since they are displayed with high cancer specificity and enhance tumor virulence via the mentioned diverse mechanisms.
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A, Series B
- Geography: France, United States, Finland
Investor stats
- Total investments: 161
- Round size: Seed $768k–$6.2M; Series A $1.4M–$23M; Series B $2.5M–$33M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely still investing — raised $44M in 2021
Portfolio highlights
- Kynogon — Autodesk game middleware products, including Beast, Navigation, HumanIK and Scaleform, will no longer be available for purchase.
- Voluntis — Voluntis design digital therapeutics to people across multiple areas to self-manage their treatment improving real-world outcomes.
- DBV Technologies — DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 353
- Round size: Series A $7M–$70M; Series B $10M–$105M; Series C $12M–$100M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $755M in 2025
Portfolio highlights
- Odoo — From ERP to CRM, eCommerce and CMS. Download Odoo or use it in the cloud. Grow Your Business.
- HighLife — HighLife is driven by a mission to deliver innovative treatment options to patients suffering from heart valve diseases.
- EnginZyme — Enzymatic chemistry for cleaner ingredients in personal care, food and pharma. Enginzyme's patented EziG platform makes enzymes work at industrial scale.
Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: France, United States, Germany
Investor stats
- Total investments: 350
- Round size: Series A $3.4M–$22M; Series B $7.8M–$66M; Venture - Series Unknown $4.1M–$37M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $97M in 2021
Portfolio highlights
- Actility — Actility provides IoT connectivity and solutions to power smart cities and industries.
- Pretty Simple — Video games studio based in Paris, France. Makers of Criminal Case and Sorcery School.
- StarTower — StarTower is a resource company built specifically for fully decentralized physical infrastructure and shared interaction. Based on the exclusive RIP encryption technology, StarTower realizes the interactive sharing of multiple resources with zero loss on mobile devices, thereby providing efficient resource transmission for terminal facilities. Itprovides more efficient, secure and reliable solutions in the fields of Internet of Things, smart cities, industrial automation, healthcare, etc.
GO Capital is an independent management company and a major player in regional Seed and Venture Capital since 2003. With offices in Brittany, Pays de la Loire, Normandy, Centre-Val de Loire and the South of France, GO Capital contributes to the financing of responsible innovation in these regions. With a team of investors with complementarysectoral experience, we have a solid track-record in DeepTech. GO Capital has nearly 400 million euros under management, and mainly finances technology leaders in the digital and healthcare sectors and in the industry of the future.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: France, Canada, Israel
Investor stats
- Total investments: 141
- Round size: Seed $549k–$7.1M; Series A $2.1M–$13M; Venture - Series Unknown $974k–$9.5M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $25M in 2023
Portfolio highlights
- Axomove — Axomove specializes in the prescription of video-based physical exercises. The company's movement knowledge is used by health professionals to improve remote monitoring of their patients and to avoid Musculoskeletal Disorders (MSDs) at work.
- Olenbee — Olenbee develops fintech solutions that connect employee benefits directly to everyday card spending. The company offers a mobile application and employer platform that link meal vouchers, gift vouchers and other planned benefits to employees’ usual bank cards and accounts. Its title-restaurant product Olenfood allows food-related expenses to beidentified from card transactions and reimbursed in line with regulation. The Olengift service applies the same principle to gift vouchers without dedicated cards or closed merchant networks. Olenbee also works on additional benefit lines such as culture, sustainable mobility, sport, holidays and home office support. Its infrastructure is designed to handle eligibility rules and integrate with HR and payroll processes for employers, while providing dedicated spaces for merchants and employees.
- NeoXperiences — NeoXperiences develops technological solutions that bring audiences together around fun and interactive experiences.
Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B, Seed
- Geography: France, United States, Germany
Investor stats
- Total investments: 274
- Round size: Seed $1.1M–$4.7M; Series A $3.2M–$28M; Series B $3.4M–$63M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Ekstere — Ekstere facilitates selling and purchasing verified-quality used bicycles at a reasonable price.
- Flexvelop — Flexvelop is a fintech transforming the way businesses finance essential business equipment. "Flexing" is an innovative combination of leasing, renting and bank-financing terms offering a kind of Hardware-as-a-Service solution. Embedded as a payment solution, partnered manufacturers, vendors and brands are actively offering"Flexing" to their b2b customers for financing new business equipment right at the point of sale and in online shops. Flexvelop is operating in the verticals of office-it, hospitality equipment, medical devices or fitness equipment throughout Germany. Well-known manufacturers like Lenovo, WMF, or LaMarzocco are using Flexing openly or as a white-label solution. SMB customers flex equipment to grow flexibly without the usual investment risk – saving liquidity, tax and a clean balance sheet. Flexvelop is using its patented in-house financing technology, promoting a more sustainable circular economy in the same time. Flexing becomes the new standard for business equipment procurement for SMBs throughout Germany, Europe and beyond.
- Presto Engineering — We enable companies imagine and implement microelectronics solutions in high-value markets such as Industrial, Automotive, Communication and Medical.
Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Venture - Series Unknown, Seed
- Geography: France, Italy, Austria
Investor stats
- Total investments: 74
- Round size: Seed $268k–$3.1M; Venture - Series Unknown $556k–$8.7M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
- Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
- Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.
Angels Santé is the leading French Business Angel Network solely dedicated to Healthcare investments.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Venture - Series Unknown, Angel
- Geography: France, India, United States
Investor stats
- Total investments: 37
- Round size: Seed $1.1M–$4.6M; Angel $687k–$1.3M; Venture - Series Unknown $664k–$8.2M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Kimialys — Kimialys provides a patented and disruptive surface chemistry for biosensors, enabling the development of innovative rapid diagnostic assays.
- StemInov — StemInov is developing a stem cell therapy for inflammatory diseases with a first focus on critical care: septic shock and ARDS
- SeaBeLife — SeaBeLife is a biotechnology company that develops a range of drug candidates intended to block regulated necrosis (or regulated cell death of cells), from a family of patented molecules.
Kreaxi is a management company specializing for over 30 years in investing in the capital of innovative and technological startups with high potential.
Show more...Investment focus
- Industry: Software, Manufacturing, SaaS
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: France, Italy, Switzerland
Investor stats
- Total investments: 70
- Round size: Seed $648k–$3.6M; Series A $1.5M–$16M; Venture - Series Unknown $1.1M–$11M
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — raised $28M in 2018
Portfolio highlights
- QiOVA — QiOVA develops and markets the world's fastest laser marking and micromachining solutions for serialization and traceability market.
- Diamfab — Diamond semiconductor - DIAMFAB - Our project aims to manufacture a sustainable carbon-based diamond semiconductor !
- Diabeloop — Diabeloop is a medical device company for diabetes and closed-loop system. It also develops disruptive technological innovations to automate the treatment of diabetes.The company mission is to make accessible disruptive technological innovations that will allow people with type 1 diabetes to live the life they want. Diabeloop was founded in 2015and is headquartered in Grenoble, Auvergne-Rhône-Alpes, France.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A pioneer in private equity in France, LBO France is now a leading multi-specialist, multi-country investment platform.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: France, United Kingdom, Spain
Investor stats
- Total investments: 41
- Round size: Series A $2.9M–$18M; Series B $16M–$200M; Venture - Series Unknown $3.9M–$27M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $181M in 2021
Portfolio highlights
- Toothfairy — Winner of app of the year, for emergencies, teeth straightening, teeth whitening & prescriptions. Teledentistry and dentist available 24/7. Founded by dentists.
- Wandercraft — Self- balancing and hands free movement with the innovative self-balancing feature, Atalante allows for multi-tasking and cognitive involvement as part of treatments.
- Incepto Medical — AI solutions for medical imaging - Co-creating artificial intelligence application with doctors and distributing AI apps solutions for radiology
Octalfa is a France-based venture capital firm that offers a range of financial services.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: France
Investor stats
- Total investments: 20
- Round size: Seed $658k–$4.6M; Venture - Series Unknown $1.9M–$2.4M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Kimialys — Kimialys provides a patented and disruptive surface chemistry for biosensors, enabling the development of innovative rapid diagnostic assays.
- Sirius NeoSight — Sirius NeoSight is a biotech and pharmaceutical company that detects subclinical neo-cancers and provide treatment for it.
- Ventuno Biotech — Our biotech company is at the forefront of developing innovative cancer therapies. Our approach centers on unlocking the potential of the immune system to
Kima Ventures promotes the growth of startups, supporting them in the fastest and most effective ways.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 749
- Round size: Seed $561k–$5.5M; Pre-Seed $591k–$3.8M; Series A $1.2M–$16M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Hoora — Hoora is a mobile gaming platform that offers an instant, scrollable feed of over 200 casual and arcade mini-games playable without downloads or waiting.
- Shiplong — Shiplog creates live customer profiles to automate real-time decisions, helping SaaS teams expand, retain, and grow Net Revenue Retention.
- üma Laboratories — Laboratoires üma develops products targeting the physiological changes associated with perimenopause, menopause, and post-menopause.
Elaia is French venture capital firm focused on European digital and deep tech startups, from early stage to growth developpement. We back tech disruptors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: France, United States, Spain
Investor stats
- Total investments: 241
- Round size: Seed $1.1M–$7.6M; Series A $2.7M–$23M; Series B $4.2M–$50M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely actively investing — fresh fund, raised $154M in 2026
Portfolio highlights
- Hema.to — Flow cytometry analysis software, re-imagined. From raw FCS and LMD data to finalized report with AI-powered CellStudio.
- RelaiSanté — RelaiSanté provides a digital platform that connects hospitals and home care providers to coordinate patient return home.
- Sim&Cure — Providing Physicians with advanced endovascular treatment solutions for a better Patient Care
M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.
Show more...Investment focus
- Industry: Health Care, Software, Food and Beverage
- Stage:Venture - Series Unknown, Seed
- Geography: France, United States, Canada
Investor stats
- Total investments: 113
- Round size: Seed $1.1M–$5.4M; Venture - Series Unknown $1.2M–$5.6M
- Lead/follow: 56% lead, 44% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Haiku — L'IA et la data au service des du droit
- The Sanctuary Group — The Sanctuary Group provides aqua-cycling, indoor cycling, boxing bootcamp, yoga, dance cardio, HIIT workouts, and kids’ swim classes.
- Ascendance — Sustainable flight solutions for today & tomorrow... because cleaner aviation can't wait. With Ascendance, Fly quieter, cleaner, further.
French VC fund insanely focused on bringing massive strategic and operational support to its entrepreneurs.
Show more...Investment focus
- Industry: SaaS, Rental, Internet
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: France
Investor stats
- Total investments: 37
- Round size: Seed $336k–$2.2M; Series A $3.7M–$11M; Venture - Series Unknown $1.1M–$14M
- Lead/follow: 49% lead, 51% follow
Portfolio highlights
- Lokki — Lokki democratizes equipment rental in Europe (Based in France) Rent on Lokki.Rent Lokki, the simple tool to manage your equipment rental business with peace of mind.
- Skillup — Skillup has designed the new @Tripadvisor for professional trainings hosting over 20k trainings and 50k reviews. It aims at helping HR services to find the adequate trainig for employees.
- Napta — Napta is a SaaS solution helping companies to find the best match between their projects and their employees.
XAnge is a Franco-German team of venture capital investors that manages €450 million and invests in digital, deeptech, and impact startups.It is the innovation brand of the Siparex group, a major player in French private equity. XAnge is a key European investor in early-stage startups and is looking for game-changing startups and entrepreneurswho rock the code[s].The Paris, Ile-de-France-located company was founded in 2004.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Series A, Series B
- Geography: France, Germany, Belgium
Investor stats
- Total investments: 240
- Round size: Seed $1.1M–$8M; Series A $3M–$22M; Series B $6M–$75M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $261M in 2021
Portfolio highlights
- ELDIM — Eldim proposes photometric and calorimetric products of instrumentation allowing to qualify the ergonomic parameters and the quality of the image of the flat screens. Its customers (manufacturers of components or sreen-Sharp, Sony, Samsung, -or integrators-IBM, Apple, Valeo, Honeywell, Nokia, Motorola-) are mainly foreigns.
- Skello — Skello is the The AI HR solution for frontline teams. HR tools were designed for offices, yet 55% of the workforce works on their feet and deserves technology designed for the field. Our mission is to improve their daily lives. For managers and HR directors, Skello offers seamless management from hiring to the payslip: our AI automatestime-consuming tasks so they can anticipate and supervise while maintaining full control. For teams, Skello guarantees a transparent and collaborative experience from their very first day. In July 2026, we reached a major milestone with the announcement of €200 million in funding to accelerate our development. After 10 years spent listening to our customers, this new chapter solidifies our conviction: technology must assist and facilitate work, without ever replacing humans. Our ambition is to be the go-to AI HR management solution for all frontline teams in Europe.
- Intent Technologies — Intent Technologies provides a dedicated service platform for real estate players that allows them to optimize the operation of a heritage and build and distribute their services. The platform integrates a growing connected ecosystem including real estate managers (social and private landlords, trustee, real estate, communities, etc.), serviceproviders (facility management, energy, elevators, personal services, insurance, etc.), publishers business software (BIM, ERP, CRM, CMMS, BI, etc.) and IoT solution providers.
Credit Agricole is a banking corporation with focuses on corporate and investment banking, retail banking, and savings management. Crédit Agricole Group is a responsible, helpful bank serving 49 million customers, 7.4 million mutual shareholders, and 1.2 million shareholders. Crédit Agricole Group supports its customers in their plans and projectsin France and around the world, through its operations in all segments of the market including insurance, real estate, payment systems, asset management, leasing and factoring, consumer finance, and corporate and investment banking. Crédit Agricole also stands out for its dynamic, innovative corporate social responsibility policy serving the economy. This policy is based on a pragmatic approach that permeates throughout the entire Group and engages all its employees. Its recent inclusion in the Vigeo-NYSE Euronext extra-financial indices is recognition of this engagement.
Show more...Investment focus
- Industry: Energy, Health Care, Software
- Stage:Debt Financing, Seed
- Geography: France, United States, Italy
Investor stats
- Total investments: 184
- Round size: Seed $837k–$6M; Debt Financing $2.1M–$1.3B
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — raised $300M in 2023
Portfolio highlights
- Crelan — Daar wordt u beter van - C'est mieux pour vous
- Bohr Energy — Bohr Energy is an artificial intelligence firm that aims to make the energy market accessible to independent producers.
- Brenus Pharma — Brenus Pharma develops off-the-shelf, next-generation in vivo immunotherapies designed to unlock the immune response against solid tumors.
Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: France, United States, Switzerland
Investor stats
- Total investments: 128
- Round size: Series A $2.4M–$14M; Series B $3.8M–$33M; Series C $4.4M–$38M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $57M in 2013
Portfolio highlights
- Isocell — Our food supplements are:natural, safe, and clinically proven
- Availpro — D-EDGE empowers 17,000+ hotels to boost revenue with CRS, Booking Engine, Channel Manager, hospitality-focused websites & digital marketing solutions.
- Nexthink — Discover what your employees need, see what they experience, know how they feel. Deliver IT that delights.
BNP Paribas Développement is the investment arm of BNP Paribas that specializes in SME development. It specializes in second stage, mezzanine, bridge, acquisition, leveraged buyouts, management buyouts, recapitalization, special situations, and privatizations transactions.The firm considers investments in manufacturing, service industries,medicine, electronics, energy, chemistry, new materials, industrial automations, industrial goods and services, transportation, consumer goods, commerce and distribution, buildings and public works, wholesale retail, biotechnology, telecommunications, and information technology sectors.BNP Paribas Développement was established in 1988 and is based in Paris, France.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 150
- Round size: Seed $2M–$7M; Series A $3.9M–$24M; Venture - Series Unknown $3.4M–$27M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
- Proteor — Proteor offers a complete range of high quality products and services to the O&P world, through more than 60 clinics.
- Ostrea — OSTREA is a pioneering company in the creation of high-performance materials based on bio-minerals: seashells.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Sham Innovation Sante is an innovation capital vehicle controlled and held by Sham, a mutual insurer specialized in risk management for health care, social welfare and community health organizations. Advised by Turenne Capital, Sham Innovation Sante's mission is to support innovative businesses in the health care sector through the growth anddevelopment phases of their life cycle.
Show more...Investment focus
- Industry: Biotechnology, Medical Device, Medical
- Stage:Series B, Series A, Venture - Series Unknown
- Geography: France
Investor stats
- Total investments: 16
- Round size: Series A $6.1M–$74M; Series B $10M–$80M; Venture - Series Unknown $1.8M–$12M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Cairdac — Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.
- Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
- Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Finovam Gestion is an investment company approved by the AMF which takes minority stakes in innovative SMEs with high growth potential.The company, which manages €50M, invests in companies that have developed innovative offers in the following target sectors: Information and Communication Technology, Health and Biotechnologies, Agro-resources andEcotechnologies.Finovam Gestion has built solid relationships with the ecosystem of entrepreneurship (Industrials, Poles of Competitiveness, Incubators, Accelerators, Universities, and Research Centers) in all the sectors that we target in order to be able to source and do emerge the best companies.Among our investors (LPs), we can count BPI France, manufacturers (ADEO, LESAFFRE, TEREOS), banks (BNP Paribas, Caisse d´Epargne, Crédit Agricole) and the Haut de France and Grand-Est regions.
Show more...Investment focus
- Industry: Software, Information Technology, Medical
- Stage:Seed, Series A
- Geography: France, United States
Investor stats
- Total investments: 44
- Round size: Seed $513k–$3.4M; Series A $530k–$18M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Pikkopay — Pikkopay provides a mobile payment solution that transforms customer smartphones into cash registers. Customers can scan items, pay, and go, eliminating the need for traditional checkout lines. The service aims to streamline the shopping experience and increase user retention rates. Pikkopay is designed to save time for both customers andretailers, offering a hassle-free shopping experience.
- StemInov — StemInov is developing a stem cell therapy for inflammatory diseases with a first focus on critical care: septic shock and ARDS
- Lattice Medical — Lattice Medical also provides solutions for improving tissue engineering and regenerative medicine using 3D-printed bio-resorbable scaffolds.
Mutuelle d'Assurance du Corps de Santé Français (MACSF) is the provider of insurance to health professionals. MACSF protects and accompanies 950,000 members of all medical and paramedical specialties, offering professional and personal solutions in insurance, savings, financing, and pensions. Its products and services meet the real needs ofits members by accompanying them in the evolution of their profession and their projects.MACSF was founded in 1935.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Medical Device
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: France, Spain, Ecuador
Investor stats
- Total investments: 26
- Round size: Seed $1.1M–$24M; Series A $7.7M–$45M; Venture - Series Unknown $2.2M–$80M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- DESTIA Group — DESTIA Group is a provider of personal services to different aged people.
- Enodia Therapeutics — Enodia Therapeutics pioneers targeted protein degradation at the Sec61 translocon, developing small-molecule therapies for inflammatory and autoimmune diseases.
- RDS — RDS is a healthcare technology startup that specializes in remote patient monitoring solutions. The company's primary product, MultiSense®, is designed to help healthcare professionals continuously monitor patients' physiological parameters, whether they're in a hospital or at home. This innovative and multi-patented technology isaimed at improving patient pathways, which in turn enhances the quality of life and care efficiencies. The company's market is primarily hospitals (particularly surgical departments) and institutions that are looking for ways to improve patient care and reduce hospital stays. By facilitating early hospital discharge and continuous monitoring, RDS solution can contribute to significant healthcare savings. The MultiSense® solution is now CE marked (MDR) and is available for sale in several European countries. The company generates recurring revenues by providing the solution on a “fee for a service” business model to healthcare institutions and professionals. The product has been well-received in the market, earning multiple awards and the support of a vibrant community of clinicians. In addition to its primary product, RDS also provides services that help healthcare systems become more attractive and sustainable. This includes training and support for healthcare professionals to effectively use the MultiSense® technology. Keywords: Healthcare Technology, Remote Patient Monitoring, MultiSense®, Patient Pathways, Care Efficiencies, Hospital Discharge, Healthcare Savings, Clinicians, Physiological Parameters, Our main product, MultiSense®, is a comprehensive Remote Patient Monitoring Solution. MultiSense® offers healthcare professionals a high-precision, multi-parametric solution to continuously monitor patients’ physiological parameters in the hospital and beyond. MultiSense® combines a wearable patient monitor designed to capture high-accuracy physiological data with a cloud platform that helps transform these data into actionable clinical insights. MultiSense® is a patented medical device that has received multiple awards. MultiSense® has been validated by 6 completed clinical investigations.RDS relies on a talented and international team with deep subject-matter-expertise and a proven track record in the Healthcare and Medical Device sector. At RDS, we all share the same passion for bringing patient pathways to the next level.
Nord France Amorçage is a regional co-investment fund, exclusively supported by the Hauts-de-France Region. This seed fund has been involved since 2013 in financing innovative businesses that create jobs and add value to the region. In 6 years, NFA has more than 50 participants spread across the region.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: France, United States
Investor stats
- Total investments: 47
- Round size: Seed $421k–$2.8M; Series A $1.1M–$25M; Venture - Series Unknown $1.1M–$8.6M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Ensweet — Ensweet is a telemedicine platform intended to offer telerehabilitation services to patients. They offer equipment so that everyone can exercise whenever possible, enabling patients to have accessible rehabilitation.
- Hemerion — Advancing cancer therapies with Hemerion Therapeutics' innovative technology to fight brain cancer and glioblastoma.
- Lattice Medical — Lattice Medical also provides solutions for improving tissue engineering and regenerative medicine using 3D-printed bio-resorbable scaffolds.
IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: France, Brazil, Singapore
Investor stats
- Total investments: 54
- Round size: Seed $1.7M–$5.8M; Series A $3.7M–$13M; Venture - Series Unknown $1.3M–$12M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Donecle — Automated aircraft inspections by drone for airlines and MRO. Donecle makes aircraft maintenance faster, safer and more reliable. Our unique technology combines 100% automated drone and image analysis algorithms to detect defects, lightning strikes, evaluate paint wear and check placards.
- Nepting — NEPTING is a company specializing in payment solutions and services with the main objective of supporting business in its evolution. Listening to its customers, it brings a skill, a culture, an innovative offer for all existing, emerging and future payment methods.NEPTING equips all types of points of acceptance with its multi-channel andmulti-vendor electronic payment system and its secure solutions in compliance with the standards in force. It is distinguished by its ability to give its customers the many advantages of a single and homogeneous offer for all its sales channels: mPOS, Retail, TPE, Automate, e-commerce ...
- ThIA Santé Mentale —
Extens believes that the healthcare industry is undergoing profound transformation and that information and communication technologies (ICTs) will gradually bring about, and today, considerable improvements. E-health will contribute to the transformation of health pathways by improving the performance of care, allowing a better quality of life atall stages of life and reducing the inefficiencies of our health systems.
Show more...Investment focus
- Industry: Medical, Health Care, Apps
- Stage:Venture - Series Unknown, Private Equity
- Geography: France
Investor stats
- Total investments: 7
- Round size: Venture - Series Unknown $1.4M–$8.5M
- Lead/follow: 71% lead, 29% follow
- Last fund: Likely still investing — raised $108M in 2022
Portfolio highlights
- Kayentis — With a 95.9% recommendation rate in 2026, Kayentis is a trusted partner for biotech, emerging biopharma, and global pharmaceutical companies. Since 2005, Kayentis has supported pharma, biotechs, and CROs by capturing meaningful patient input. With user-friendly eCOA technology and top-quality services, we ensure high quality datasets and improve the experiences of patients and sites. Challenge your eCOA vendor and embark on a seamless eCOA clinical trial experience with us!
- Keenturtle — Keenturtle is a medtech that provides e-health solutions to enhance medical & economic field such as provision of health data.
- DigitecPharma — DigitecPharma is a SaaS powered mobile application platform for patient relationship management for pharmaceutical dispensaries.
Banque des Territoires is a Investment Firm.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: France, United States
Investor stats
- Total investments: 103
- Round size: Seed $1.4M–$7.6M; Series A $4M–$30M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Semeia — Semeia provides software that helps in medical follow-up and consultation.
- Aquassay — Aquassay assists you with improving the industrial and environmental performance of all your water usage (supply, production, discharge).
- Click&Care — Click&Care is a caregiver marketplace empowers families to easily find, manage and pay licensed caregivers online. Click&Care is a transformation in quality homecare that contribute to make it more affordable and accessible.
Isai is a tech entrepreneurs' fund that focuses on early-stage internet startups and small capital tech private equity deals. It seeks to invest in companies operating in the software, information technology, media, and industrial sectors. It brings together more than 300 tech entrepreneurs who have decided to invest their money and theirexperience in order to allow the emergence of new French Tech champions.Founded in 2010, Isai is headquartered in Paris, France.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 185
- Round size: Seed $999k–$7.5M; Series A $2.9M–$22M; Series B $6M–$50M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $329M in 2024
Portfolio highlights
- Kheops — Kheops is a tool that shops and producers use to search and order local products.
- Panora — Panora's goal is to provide a clear and structured perspective of their business, files, and opportunities.
- APL Datacenters — Organic Design, des #datacenters en symbiose avec leur environnement
ODYSSEE VENTURE is a French Venture Capital and Private Equity firm. It was founded by Mathieu Boillet and Sébastien Sassolas in 1999 and is based in Paris, France. The company has raised over 600M€.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: France, United States
Investor stats
- Total investments: 87
- Round size: Seed $878k–$6.9M; Series A $1.6M–$11M; Venture - Series Unknown $1.7M–$16M
- Lead/follow: 75% lead, 25% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Kheops — Kheops is a tool that shops and producers use to search and order local products.
- ENGO Eyewear — engo3 is a next generation heads up display built for endurance athletes. Instant, frictionless, hands free access to performance metrics with long battery life and an ultra lightweight form factor. Unlock your data, and experience an entirely new way to train and compete
- Elixir Aircraft — Discover Elixir Aircraft, manufacturer of 4th generation light aircraft focusing on safety, savings, versatility, and sustainability in general aviation.
IRDI Gestion aims to participate in the economic growth and job creation in their regions. For this, their teams create a real partnership with the companies they accompany, based on a relationship of trust and proximity.IRDI Gestion currently manages €150 million and has financial tools able to accompany the Southwest SMEs in the creationphase, development or transmission, with intervention tickets from equity € 100000 to € 5000000.Precursor of regional investment capital of the Southwest, with a presence of over 35 years, the IRDI Group consists of 3 SCR:- IRDI, created in 1981 to foster industrial growth companies based in the South West of France- MPcroissance, created in 1996 to assist small businesses in Midi-Pyrénées- IRDInov, created in 2012 under the leadership of the National Seed Fund (under the PIA) to fund the initiation of innovative companiesIn 2015, the management company IRDI Gestion, approved by the AMF, was formed to structure the group and bring new development projects.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: France
Investor stats
- Total investments: 46
- Round size: Seed $757k–$9.2M; Series A $1.6M–$23M; Venture - Series Unknown $1.3M–$23M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- FineHeart — Our mission is to address the unmet need of patients with sever heart failure
- REEV — REEV motorizes medical orthoses to help millions of people affected by gait disorders to walk, stand, sit and climb stairs with greater ease every day.
- Starfish Bioscience — STARFISH Bioscience focuses on the creation and development of microbiological solutions for agriculture and vineyards. Our objective is to regenerate soils by restoring their microbiomes, increasing sustainability and productivity while minimizing environmental impact. We are dedicated to improving humanity's well-being and preserving theearth by inventing technologies that address the future difficulties of global agriculture.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Crédit Mutuel Innovation is the evergreen venture capital entity of Crédit Mutuel Equity (€3.5 billion in capital). We invest €1-20M in life science, digital and deeptech companies from seed to growth stages.We help bold and ambitious entrepreneurs to develop their strong growth potential with our worldwide enterprise ecosystem (our 350+portfolio companies, our abroad subsidiaries, 150+ largest global corporates and the best-in-class experts). Because it takes more than 5 years to build a Unicorn, we invest our own equity and ensure durable partnerships with visionary leaders.Today, the 350 companies in which we have invested generate a cumulative annual turnover of €50bn and create more than 250,000 jobs.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Venture - Series Unknown
- Geography: France, United States, Belgium
Investor stats
- Total investments: 109
- Round size: Series A $3.4M–$26M; Venture - Series Unknown $2.4M–$24M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- e-peas — Discover e-peas, pioneer of the Ambient IoT concept since 2014, which offers the most efficient energy harvesting pmics on the market to make your devices more energy self-sufficient: AEMs.
- Ever Dye — A new standard for dyes. Naturally made, carbon emissions reducing, water protecting.
- Standing Ovation — Animal-free dairy cheese
We turn exceptional individuals into funded founders. We back you first, then give you a bridge to Silicon Valley.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Singapore, United States
Investor stats
- Total investments: 485
- Round size: Seed $54k–$6.7M; Pre-Seed $55k–$2.7M; Series A $5.1M–$41M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely actively investing — fresh fund, raised $133M in 2026
Portfolio highlights
- ByteAsk — Derisk your AI agents
- Sourcepulse — Your early warning system for software delivery (YC S23)
- Open Cosmos — Open Cosmos design, build and operate space missions, providing straightforward access to high quality satellite data and insights on a global scale.
Newfund is a $300M entrepreneurial VC firm dedicated to pre-seed and seed investments in France and North America, in companies driving global change. The company is always looking for founders who are driven to realize a vision that will significantly alter the world in which we live. In order to appreciate what entrepreneurs are creating andutilize their strengths, Newfund aims to comprehend entrepreneurs as unique individuals.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: France, United States, Canada
Investor stats
- Total investments: 208
- Round size: Seed $1.1M–$5M; Series A $1.4M–$15M; Venture - Series Unknown $850k–$8.4M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $65M in 2023
Portfolio highlights
- Moodwork — Moodwork provides a digital platform for workplace mental health that combines AI with human expertise to support employees through assessments, guidance, and access to professional resources. The platform also delivers anonymized workforce insights, enabling organizations to monitor mental health trends, protect employee privacy, and supportinformed workplace decisions.
- AI-Stroke — Developer of an artificial intelligence-powered mobile application designed to assist in pre-CT/MRI stroke diagnostics. The company offers a platform that guides first responders and patients through relevant exercises for stroke detection, captures and analyzes video data, and leverages the world's largest proprietary stroke patientvideo dataset (20,000 videos and 6 million images), enabling patients with a diagnosis and outcomes by reducing delays in treatment for stroke, increasing the number of treatment procedures, and recuding the rehab costs.
- Discernis — Home | Discernis AI-Native Discovery
The private equity fund focused on adding high value.IXO Private Equity is a private equity management company recognized, approved and authorized by the Financial Market Authorities (AMF) operating under the number GP03018.IXO Private Equity is the most important independent regional private equity General Partner in France.The companymanages French General Private Equity Investment Funds (known in France as F.C.P.R.), Local Private Equity Investment Fund (known in France as F.I.P.), and Private Equity Investment Funds for Innovation (F.C.P.I.) to meet the equity needs for the best companies in Western and Southern France.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Private Equity, Venture - Series Unknown, Series A
- Geography: France, United States, Canada
Investor stats
- Total investments: 68
- Round size: Series A $2.2M–$13M; Private Equity $3.3M–$22M; Venture - Series Unknown $1.8M–$12M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $74M in 2020
Portfolio highlights
- Indy — Indy offers end-to-end and advanced AI-powered accounting software. Indy is an accounting robot that aims to automate the accounting of freelancers and professionals. It is an accounting robot for the liberal professions. It automates the management of accounting, recovers bank entries to turn them into accounting lines, and sends tax returnsdirectly to an AGM.It was founded in 2016 as Georges by Côme Fouques, Pablo Larvor, Romain Koenig, and Adrien Plat to simplify independent accounting, which is certainly simple but repetitive and time-consuming.
- Wecasa — Wecasa is a data-driven marketplace that revolutionizes care services by focusing on user experience for customers and professionalsWecasa's mission is to make care services simple and accessible for a better quality of life. Through its app, users can book in seconds a reliable Professional for care services at home: wellness (haircut,beauty, massage), cleaning, and childcare. Available in Paris, top cities in France, London, and more European cities to come. Wecasa is proud to help 100.000+ customers and increase the business of 3000 independent professionals.
- MyC — Reduce and better manage health-related risks with MyC.
Innovacom provides new technologies, hardware, and software products. They focus on the creation of financial and strategic value through support, networking, and the search for the best industrial partners for our startups in a context of open innovation.
Show more...Investment focus
- Industry: Software, Mobile, Telecommunications
- Stage:Series A, Series B, Series C
- Geography: France, United States, Canada
Investor stats
- Total investments: 153
- Round size: Series A $2.7M–$19M; Series B $3M–$58M; Series C $4.4M–$44M
- Lead/follow: 30% lead, 70% follow
- Last fund: Likely still investing — raised $23M in 2023
Portfolio highlights
- Quobly — Quobly create and market a universal large-scale quantum computer, using tried-and-true semiconductor industry procedures.
- Faactopi — Faactopi accelerates manufacturing for high-tech innovations with flexible, cost-efficient services ensuring rapid time-to-market and uncompromising quality.
- Elixir Aircraft — Discover Elixir Aircraft, manufacturer of 4th generation light aircraft focusing on safety, savings, versatility, and sustainability in general aviation.
Bpifrance Digital Venture operates as a venture capital firm.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Series A, Seed, Pre-Seed
- Geography: France, India
Investor stats
- Total investments: 32
- Round size: Seed $1.9M–$18M; Pre-Seed $439k–$1.8M; Series A $2.9M–$21M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- AbTx — Antibody for Therapy
- Delos — The French flair striking hard in AI
- Lightspring — Lightspring is a photonics technology company developing advanced 3D optical interconnection solutions for photonic systems.
Partech is a global venture capital firm with offices in San Francisco, Paris, Berlin and Dakar. Partech invests in Internet and information technology startups at seed, venture and growth stages.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Seed, Series A, Series B
- Geography: France, United States, Germany
Investor stats
- Total investments: 694
- Round size: Seed $1M–$8.8M; Series A $4.5M–$28M; Series B $9M–$56M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely actively investing — fresh fund, raised $345M in 2026
Portfolio highlights
- Modeinspect — acreom is the integrated markdown knowledge base with tasks. Your personal daily driver for your dev workflow.
- TeamToolz — TeamToolz creates and implements user-friendly applications that simplify and streamline the creation, management and archiving of marketing communications. Addressing the urgency of time to market, our web-based tools better enable entire brand launches by coordinating the workflow of multiple outside agencies and internal groups, for moreintegrated worldwide brand management.
- Revibe — Buy refurbished & used electronics (Smartphones, Laptops) in UAE at Revibe. Free delivery & 12 months warranty. Certified tech by our experts. Order Now!
Partech is a global venture capital firm with offices in San Francisco, Paris, Berlin and Dakar. Partech invests in Internet and information technology startups at seed, venture and growth stages.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: France
Investor stats
- Total investments: 8
- Round size: Seed $2.3M–$3.3M; Series A $5.7M–$18M; Series B $8.8M–$22M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Sensome — Sensome develops a breakthrough remote monitoring technology that can turn invasive vascular medical devices into connected healthcare devices. By providing ins
- DAMAE Medical — Damae Medical is a Paris, France-based medtech company. It has developed a medical device capable of seeing biological tissues in depth, at a cellular level and in vivo. This innovative optical imaging technology will especially allow dermatologists to evaluate in a precise, efficient and rapid way malignancy of tumors by a simple contact with thesurface of the skin. DAMAE Medical’s mission is to put the great power of bio-photonics at the service of opening new opportunities in medical imaging and diagnosis.
- Stilla Technologies — Stilla Technologies is taking digital PCR to a whole new level with a unique 6-color target detection capability
Pays de la Loire Participations provides finance innovation, productivity and development, especially in a banking context that is increasingly constrained by standards and regulations.The Pays de la Loire region has created the "Pays de la Loire Participations" co-investment fund (PLP) intended for small and medium-sized companieswishing to strengthen their equity. By investing alongside private professional investors, it facilitates risk taking and helps anchor long-term skills on the territory and promotes job creation and wealth.With 14 million euros in capital (20 million in the long term), entirely contributed by the Region, the "Pays de la Loire Participations" fund co-invested an average of around 2.5 million euros annually. average of € 180 K per company. Its intervention as a co-investor is crucial because it allows the VSE / SME beneficiaries to obtain from private financiers and banks, 4 times the funds contributed by Pays de la Loire participations.
Show more...Investment focus
- Industry: Manufacturing, Software, Information Technology
- Stage:Seed, Venture - Series Unknown, Private Equity
- Geography: France
Investor stats
- Total investments: 52
- Round size: Seed $559k–$3M; Venture - Series Unknown $787k–$5.8M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- CGREEN — CGREEN is developing a biosourced, low-carbon carbon fiber derived from cellulose — a renewable, local, and abundant resource.
- Eclore — Eclore utilizes origami-inspired designs to produce cylindrical and flat protective bellows, as well as specific protection kits for SCARA robots. These components are constructed from materials resistant to solvents, oils, ultraviolet rays, and high-pressure cleaning while maintaining compliance with international standards. The products functionthrough compression and expansion cycles to safeguard equipment from environmental contaminants and mechanical wear. By reducing the total number of parts and overall bulk, the folding technology creates lightweight protective barriers suitable for various industrial diameters.
- Miura Simulation — Miura helps engineers take control of their data, connect tools, reduce vendor friction, and lay the foundation for scalable AI.
iBionext is a unique healthcare fund created within a proven breakthrough innovation accelerator. Their companies are based in a single location named “Passage de l’innovation” in Paris, France. Over the past 4 years, we have created 7 companies that have raised over 250M € and created 103 highly qualified jobs.
Show more...Investment focus
- Industry: Medical Device, Artificial Intelligence, Drones
- Stage:Venture - Series Unknown, Series A, Series B
- Geography: France
Investor stats
- Total investments: 14
- Round size: Series A $8.2M–$15M; Series B $15M–$39M; Venture - Series Unknown $2.7M–$14M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $113M in 2018
Portfolio highlights
- BrainEver — BrainEver is developing a portfolio of drug candidates focused on major neurodegenerative diseases with significant unmet medical needs: ALS, Parkinson, and
- Prophesee — Prophesee brings Event-Based Vision technology, software and AI together to detect, track and measure fast change in demanding environments.
- Tilak Healthcare — Tilak is a unique videogame studio where like-minded & passionate people create fun mobile medical games to monitor patients with chronic diseases.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Région Sud Investissement is an investment Firm.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: France, Spain
Investor stats
- Total investments: 62
- Round size: Seed $1.1M–$5.8M; Series A $2.2M–$24M; Venture - Series Unknown $1.3M–$12M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Agriodor — Agriodor is to provide concrete and effective alternatives to insecticides to help farmers produce more sustainably.
- cosma — Cosma observes, maps and monitors the seabed to deliver open, neutral and affordable data at global scale.
- ANA Healthcare — ANA Healthcare provides innovative healthcare data management solutions with a focus on security, compliance, and user experience.
On-the-ground expert investors in early-stage digital. Ready to meet you, wherever you are.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Series A, Seed, Series B
- Geography: France, Germany, United States
Investor stats
- Total investments: 217
- Round size: Seed $1.3M–$6.6M; Series A $3.9M–$14M; Series B $5.6M–$67M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fresh fund, raised $207M in 2025
Portfolio highlights
- amber — info@amberoad.aiambeRoad is developing an intelligent enterprise search engine to help employees to find all relevant documents easily and quickly by integrating all company internal data sources into one search engine. Our solution allows access to all company-wide files from anywhere. Even if you don't exactly know what you are lookingfor, our cutting-edge AI will know because of a range of features implemented in our software.No need to tag documents manually, all in milliseconds - only one search request away.
- Credoxys — Credoxys develops organic electronic materials for OLED displays, OLED lighting, organic photovoltaics, and sensors. Its portfolio includes dopants and transport materials designed to influence charge transport, optical transmission, power consumption, and energy generation in organic electronic devices. The company also develops materials forscale-up and customer-specific applications.
- ENGO Eyewear — engo3 is a next generation heads up display built for endurance athletes. Instant, frictionless, hands free access to performance metrics with long battery life and an ultra lightweight form factor. Unlock your data, and experience an entirely new way to train and compete
Cemag Invest is a family office founded in 2016 dedicated to minority capital development investments in the fields of healthcare, B to B services, and technology.
Show more...Investment focus
- Industry: Medical, Health Care, Artificial Intelligence
- Stage:Series B, Series A, Private Equity
- Geography: France
Investor stats
- Total investments: 13
- Round size: Series A $7.5M–$11M; Series B $7.9M–$34M; Private Equity $17M–$18M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Advicenne — Specialty pharmaceutical company focused on the development of pediatric friendly therapeutics for the treatment of orphan renal diseases and neurology.
- Diabeloop — Diabeloop is a medical device company for diabetes and closed-loop system. It also develops disruptive technological innovations to automate the treatment of diabetes.The company mission is to make accessible disruptive technological innovations that will allow people with type 1 diabetes to live the life they want. Diabeloop was founded in 2015and is headquartered in Grenoble, Auvergne-Rhône-Alpes, France.
- Wandercraft — Self- balancing and hands free movement with the innovative self-balancing feature, Atalante allows for multi-tasking and cognitive involvement as part of treatments.
Sham is a mutual insurance company that provides medical malpractice insurance in France.
Show more...Investment focus
- Industry: Medical Device, Biotechnology, Health Care
- Stage:Series B, Series A, Venture - Series Unknown
- Geography: France, United States
Investor stats
- Total investments: 18
- Round size: Series A $6.1M–$74M; Series B $3.3M–$80M; Venture - Series Unknown $1.8M–$12M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Cairdac — Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation.
- Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
- Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.
Cap Innov’Est is a 36M€ tri-regional fund dedicated to investments in young innovative start-ups. Cap Innov’Est was launched in July 2014 and has already invested in 13 start-ups. Cap Innov’Est is supported by Fonds National d’Amorçage, the 3 Regions Alsace, Bourgogne and Franche-Comté, SAFIDI, caisses d’épargne d’Alsace etBourgogne/Franche-Comté, BNP Paribas et CIFC
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: France, United States
Investor stats
- Total investments: 18
- Round size: Seed $706k–$2.8M; Series A $8.2M–$8.3M; Venture - Series Unknown $2.5M–$4.5M
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — raised $49M in 2014
Portfolio highlights
- VistaCare — "Making Difficult Wounds Easy" : VistaCare is a Breakthrough and non-invasive Medical Device designed for treatment during the critical phases of the wound.
- Opencell Software — Opencell was created in 2015 to leverage an open source telco billing project initiated in 2007 by David Meyer, their current CEO.Their mission is to provide the first agile monetization platform capable of filling the gap between costly and complex legacy billing solutions and the overly simplistic “one size fits all” SaaS solutions that coveronly the most basic requirements.Opencell is now the open source monetization and billing platform with over 40 successful implementations in multiple industries and countries.
- Rhythm Diagnostic Systems — Many of our team have worked together on different projects and in different companies over the last 30-plus years. We are experienced technology, medical, health care and biotech professionals, with long, successful histories in Silicon Valley and elsewhere.
CentraleSupélec Venture est un fonds de capital-risque early-stage, créé par l’Ecole CentraleSupélec.
Show more...Investment focus
- Industry: Medical, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: France
Investor stats
- Total investments: 9
- Round size: Seed $412k–$5.8M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Ed.ai — Ed AI provides an AI platform for automated grading, feedback, and personalized learning materials in education.
- Exwayz — Sub-2 cm 3D LiDAR SLAM localization for autonomous robots and vehicles in GPS-denied ports, tunnels, mines and race circuits.
- En Carta Diagnostics — En Carta provides low cost and high accuracy paper based diagnostics. Our first product is a SARS-CoV-2 or COVID-19 Diagnostic
Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.
Show more...Investment focus
- Industry: Software, Manufacturing, Biotechnology
- Stage:Venture - Series Unknown, Series A
- Geography: France, United States
Investor stats
- Total investments: 55
- Round size: Series A $849k–$7.2M; Venture - Series Unknown $1.3M–$11M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $26M in 2013
Portfolio highlights
- Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
- Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
- Mon Chasseur Immo — Mon Chasseur Immo is a Real Estate, based in Languedoc Roussillon.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Energy, Health Care
- Stage:Debt Financing, Post-IPO Debt, Venture - Series Unknown
- Geography: France, Germany, Spain
Investor stats
- Total investments: 595
- Round size: Post-IPO Debt $18M–$587M; Debt Financing $16M–$355M; Venture - Series Unknown $8.7M–$90M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- VaxThera — VaxThera develops and produces vaccines to prevents and treats diseases.
- Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
- Reactive Technologies — Reactive Technologies we are committed to enabling a more intelligent use of energy, for the largest and most complex business to the smallest household. Our aim is to develop new technologies that will positively assist the energy industry to deliver cleaner, greener and more affordable energy, through more efficient and effective energymanagement and control. Through our innovative, cloud-based solution for Corporate customers – Tradenergy® – we have begun this process and with our pipeline of ground breaking new technologies we intend to continue.
Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: France, Norway
Investor stats
- Total investments: 34
- Round size: Seed $392k–$3.3M; Series A $1.3M–$7.8M; Venture - Series Unknown $1M–$6.5M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Aéronde — The Aéronde is an innovative electric airship with a toroidal shape (giant donut) of 15 meters in diameter, designed to offer a silent, energy-efficient flight with very low environmental impact. Inflated with approximately 400 m³ of helium, it can carry up to two people and equipment, with a payload of 200 kg .
- Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
- BiPER Therapeutics — BiPER Therapeutics is a biotech company to develop and commercializes novel therapeutics.
Crédit Mutuel Equity is the Private Equity branch of Crédit Mutuel Alliance Fédérale.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Food and Beverage
- Stage:Private Equity, Venture - Series Unknown, Series A
- Geography: France, Canada, Germany
Investor stats
- Total investments: 143
- Round size: Series A $3.5M–$11M; Private Equity $2.6M–$89M; Venture - Series Unknown $3.5M–$46M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Proteor — Proteor offers a complete range of high quality products and services to the O&P world, through more than 60 clinics.
- Maisons SOCOREN — Marcel Thireau created Les Maisons Socoren in 1981 after having held important positions in two leading companies in the building sector.Born in Angers, the company is now present in Laval, Le Mans, Nantes (La Chapelle sur Erdre), Vannes, Angers, Alençon, Ifs, Rennes (Brécé), Saint-Brieuc, Villedieu-les-Poëles, Valognes .Every year, your homebuilder builds more than 600 single-detached homes throughout the Greater West. Since its creation, it has enjoyed a strong and constant development, occupying one of the top ten places on the French market.Its seniority is one more guarantee for customers, assured to address a stable company that has always met the quality requirements.Its success is due to the desire to favor direct proximity with each client, responsiveness to offer new services and adapt to changing needs.Marcel Thireau, his collaborators, his partners (some have followed him since the beginning) knew how to design and maintain a rigorous organization of work and follow-up which ensured the growth of the company, while allowing thousands of families to make the best investment possible: the construction of their house.
- Athos Services Commémoratifs —
Medical VC funding in France at a glance
Stats across 798 deals from 716 investors.
Access all 716 VC funds in France Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in France investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 716 VC funds investing in France Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!